Polfarmex S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-04-20
Share capital
7,006,340.00 PLN
Activity description

Polfarmex is a Polish manufacturer of generic medications that has been providing high-quality, affordable, and safe pharmacological therapies for 35 years. The company offers prescription and over-the-counter drugs, dietary supplements, and cosmetics, with 80% of its products developed in-house. Polfarmex operates in 15 foreign markets, expanding its presence in Europe and beyond.

Registered address
Józefów 9, 99-300 Kutno, Poland
Branches
  • ul. Poleczki 35, 02-822 Warszawa
Email
Phone
Social media
Electronic delivery address
AE:PL-29451-11218-ABGBT-15

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$3,407

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 82 days late). All were audited by a statutory auditor.

  • 202510/07/2026
  • 202411/07/2025
  • 202311/07/2024
  • 202210/07/2023
  • 202105/10/2022
  • 202005/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing978 / 24,570
Top 4.0%
City · Kutno6 / 193
Top 3.1%
Voivodeship · Łódzkie130 / 15,329
Top <1%
Country · Poland3,134 / 297,266
Top 1.1%

Results vs industry

Revenue
This companyUSD 73.54mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -140.80kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 60.58mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 117.79mMedianUSD 897.46kAverageUSD 31.52m

Websites

The sites are available in: Polish and English.

  • polfarmex.plPolfarmex S.A.
    WordPress 7.1ElementorYoast SEOApache
  • bezzakazen.plZakażenia grzybicze – rodzaje grzybicy, porady, testy
    WordPress 7.1Google AnalyticsGoogle Tag ManagerLiteSpeed
  • polfarmex-intranet.plPolfarmex S.A.
    Apache

Public procurement

The company is the contractor in one public sector contract, worth USD 2.70k.

SubjectAmount
Sponsorship agreement for Święto Róży 2026
$2,701

Trademarks

The company holds 159 active trademarks registered with the Polish Patent Office. 1 application is pending. 84 marks have expired or were not registered. The first mark was filed in 1998.

MarkNumberClassesStatusProtected until
ŻUK (word)Z.5927169, 28Protected Oct 25, 2035
DIAZARD (word)Z.5871155Protected Jul 7, 2035
FLUXOGIN (word)Z.5853365Protected May 29, 2035
APROPOL (word)Z.5591175Protected Aug 9, 2033
CALCIFOS (word)Z.5591205Protected Aug 9, 2033
MarkProtected until
ŻUK (word)Oct 25, 2035
DIAZARD (word)Jul 7, 2035
FLUXOGIN (word)May 29, 2035
APROPOL (word)Aug 9, 2033
CALCIFOS (word)Aug 9, 2033

Job offers

The company has its own careers page: polfarmex.pl.

Authorized Representatives

Bogdan Szczepan Manowski age 54 – Vice President of the Management Board
Jarosław Kazimierz Walczak age 57 – Management Board Member
Marek Piotr Wośko age 61 – President of the Management Board

Manner of representation

Authorised to make declarations of will on behalf of the company are: 1) the President of the Management Board independently; 2) two members of the management board acting jointly; 3) a member of the management board acting jointly with a commercial proxy.

Supervisory board

Melania Anna Podziewska age 50 – Supervisory Board Member
Wojciech Cezary Wośko age 60 – Supervisory Board Member
Katarzyna Elżbieta Wośko age 50 – Supervisory Board Member
Iwona Szadkowska age 56 – Supervisory Board Member
Magdalena Kossakowska age 44 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
46.6667%
23%

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$1.5M
Buildings and premises
$25M
Investment property
$43,787

MSiG notices

Publication dateEvent
Jan 26, 2022Commercial Companies Code notice
May 23, 2016Merger plan
Aug 5, 2015Transformation registered

Public aid

20 public aid cases recorded, with a total value of $2,102,857.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$26,061
De minimis aid (in accordance with Commission Regulation 2023/2831)
$10,905
Aid for research and development projects: experimental development
$400.2K

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active
Integrated permit Active

Competitors

Name
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Farmak International sp. z o.o.
Sandoz Polska sp. z o.o.
Orifarm Manufacturing Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
SUN-Farm sp. z o.o.
Poznańskie Zakłady Zielarskie Herbapol S.A.
Tactica Pharmaceuticals sp. z o.o.

Change history

DateEvent
2015-03-05Share capital increase
2015-03-05PKD change
2014-10-29PKD change
2011-08-31PKD change
2010-08-31Switch to PKD 2007

FAQ

Last updated: 2026-07-16